TSBX: Dhuwit awis diétung saben siji saham turnstonebio.com

Turnstone Biologics Corp. - logo grafis emiten TSBX

The development of Turnstone Biologics (TSBX) relies on the efficacy of TIL therapy and the speed of creating personalized cells. On GURU.Markets, the issuer's cash per share demonstrates liquidity, where 0.79 captures the value of this parameter. Simultaneously, the company is implementing energy saving in its laboratories, which facilitates the expansion of its medical center network due to high demand for the treatment of solid tumors.

Turnstone Biologics Corp (TSBX) - Dhuwit awis saben saham saka 21.02.2024 nganti 24.08.2025

Rincian metrik komprehensif lan analitis Turnstone Biologics Corporation (TSBX)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator anane dhuwit lan arus kas:
Analisis komprehensif perusahaan:Turnstone Biologics Corporation (TSBX)
Barang unggulan Turnstone Biologics Corp

Liquidity control is a key element of risk management when establishing a long-term position. For Turnstone Biologics (TSBX), which focuses on its own tumor research without external mergers, a capital reserve is critically important. The cash per share trend reflects the volume of free funds attributable to a single security, allowing for the tracking of the resource burn rate. A decline in this metric signals liquidity erosion prior to official reports, while a high value confirms the financial stability of Turnstone Biologics (TSBX) upon the completion of early-stage tests.

Perusahaan pesaing

IBRX - Volume dana dhuwit saben saham|Dhuwit awis saben siji saham IMCR (Immunocore PLC)|Dhuwit awis diétung saben siji saham JANX|Dhuwit awis saben saham RCUS (Arcus Biosciences)|Gunggung dhuwit awis saben saham ZYME|tangotx.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Iovance Corp|Immatics N.V. (IMTX) - Dana dhuwit saben saham|Xencor, Inc. - Gunggung dhuwit awis saben saham|CMPX (compasstherapeutics.com) - Dhuwit awis saben saham|Dhuwit awis saben saham Replimune Group Inc|Dana dhuwit saben saham Lyell Immunopharma, Inc. (LYEL)|IPHA: Dhuwit awis saben lembar saham|Pyxis Oncology - Dhuwit awis saben siji saham|Compugen Limited (CGEN) - Cekelan dhuwit saben saham|IO Biotech Inc - Dhuwit awis saben saham|Dana dhuwit diétung saben saham Sutro Bio STRO|INKT: Dhuwit awis saben saham|Cekelan dhuwit saben saham Werewolf (HOWL)|Dana dhuwit saben saham immixbio.com|Dana dhuwit saben siji saham ALXO (ALX Oncology)|Dhuwit awis saben saham CUE|PDSB (PDS Biotechnology Corporation) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham SONN (Sonnet BioTherapeutics Holdings)|Gunggung dhuwit awis saben saham MAIA|Liminatus - Dhuwit awis saben saham|lavatherapeutics.com - Dhuwit awis diétung saben siji saham|NextCure (NXTC) - Dana dhuwit saben saham|Leap Therapeutics Inc - Gunggung dhuwit awis saben saham|Dhuwit awis saben siji saham INTS|Dana dhuwit saben saham SNSE|Dhuwit awis saben saham TOVX|GRTS - Cekelan dhuwit saben saham|Dana dhuwit saben saham kinetabio.com KA|Gunggung dhuwit awis saben saham NEXI|VCNX - Dana dhuwit saben saham|Cekelan dhuwit saben saham Harpoon Therapeutics Corp